MST CONTINUS

This brand name is authorized in Cyprus, Estonia, Croatia, Ireland, Malta, Poland, United Kingdom, South Africa

Active ingredients

The drug MST CONTINUS contains one active pharmaceutical ingredient (API):

1 Morphine UNII X3P646A2J0 - MORPHINE SULFATE

Morphine is a narcotic analgesic obtained from opium. Morphine acts as an agonist at opiate receptors in the CNS particularly Mu and to a lesser extent Kappa receptors. Mu receptors are thought to mediate supraspinal analgesia, respiratory depression and euphoria, and Kappa receptors, spinal analgesia, miosis and sedation. Read about Morphine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MST CONTINUS Prolonged-release tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
MST CONTINUS Prolonged release granules for oral suspension	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02AA01	Morphine	N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1033276, 1080278, 1080289, 1080290
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 19201, 19204, 19209, 28834, 28838, 30779, 30788, 381005, 381007, 381524, 381526, 381528, 381531, 381534, 391224, 391226, 40884, 40893, 43796
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-113395944, HR-H-448781299, HR-H-734333555, HR-H-863692829
Country: IE	Health Products Regulatory Authority	Identifier(s): 35130, 35149, 35157, 35165, 53341, 53368
Country: MT	Medicines Authority	Identifier(s): AA729/33201
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100093056, 100093062, 100093079, 100093085, 100093091
Country: ZA	Health Products Regulatory Authority	Identifier(s): R/2.9/294, R/2.9/295, S/2.9/278, S/2.9/279